In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Physician-scientist Nai-Kong Cheung
Caging the Beast: MSK Researchers Design a New Radiation Treatment More Destructive to Cancer Cells

Learn about the work of Nai-Kong Cheung and other MSK scientists who have learned more about how to deliver stronger treatment with less toxicity.
DNA winding around histones
In the Lab
Research Clarifies How IDH Mutations Cause Cancer

The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.
MSK physician-scientist Omar Abdel-Wahab
In the Lab
Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.
Pedram Razavi, Jorge Reis-Filho, and Bob Li
Finding
Many Mutations Detected in Liquid Biopsy Tests Do Not Come from Cancer Cells, an MSK Study Finds

The new findings suggest the need for caution when interpreting the results from these tests.
Molecular biologist John Petrini of the Sloan Kettering Institute.
Feature
Understanding the DNA-Damage “First Responders”: John Petrini at Work

Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
Michael Postow, Nitya Raj and Triparna Sen
MSK Leaders Recognized in the 40 Under 40 in Cancer Class of 2020

Chief of the Melanoma Service Michael Postow, MD, Medical Oncologist Nitya Raj, MD, and Assistant Attending Triparna Sen, PhD were included on this year’s list.
Group photo of researchers Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra.
Feature
How MSK-ACCESS Blood Test for Cancer was Created

MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.
Nat, Alex, and Michael Wolff and Polly Draper
Fixing One Wrong Note: How MSK Precision Diagnostics Saved a Musician With a Rare Cancer

Learn how molecular testing and an experimental targeted therapy cured jazz musician Michael Wolff, who had the rare cancer histiocytic sarcoma.
MSK medical oncologist Alexander Drilon
Feature
First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.
Memorial Sloan Kettering Collaborates with Global Community on the Bloomberg New Economy International Cancer Coalition to Accelerate and Expand Access to New Therapies and Clinical Trials

The Coalition was discussed at the fourth annual Bloomberg New Economy Forum (NEF) in Singapore on November 16–19.